Encapsulating peritoneal sclerosis.

Area of Science:

• Gastroenterology
• Nephrology
• Surgical Pathology

Background:

• Encapsulating peritoneal sclerosis (EPS) is a severe condition characterized by a fibrocollagenous membrane encasing the small intestine, leading to recurrent bowel obstructions.
• While often associated with long-term peritoneal dialysis, EPS can also be linked to medications, infections, or inflammatory disorders, with many cases remaining idiopathic.

Purpose of the Study:

• To review the current literature on the etiology, pathogenesis, diagnosis, and treatment of Encapsulating Peritoneal Sclerosis (EPS).
• To highlight the diagnostic challenges and high mortality associated with EPS, emphasizing the need for increased awareness and timely intervention.

Main Methods:

• Comprehensive review of existing medical literature concerning Encapsulating Peritoneal Sclerosis.
• Analysis of diagnostic modalities, including imaging and surgical exploration.
• Evaluation of treatment strategies based on disease stage, including medical and surgical interventions.

Main Results:

• Diagnosis of EPS is frequently delayed due to its rarity, non-specific symptoms, and challenging interpretation of diagnostic findings.
• Mortality rates approach 50% within one year of diagnosis, underscoring the severity of the condition.
• Treatment strategies vary by disease stage, with corticosteroids for inflammation and tamoxifen for fibrosis, alongside supportive nutritional care and potential surgical options.

Conclusions:

• Encapsulating Peritoneal Sclerosis is a rare, potentially fatal condition requiring a high index of suspicion for timely diagnosis.
• Multifaceted treatment approaches, tailored to disease stage and patient condition, are essential for managing EPS.
• Further research into the pathogenesis and earlier diagnostic markers may improve outcomes for patients with EPS.